{
    "organizations": [],
    "uuid": "ce3be701ed40761775795110faa767e9bc6d34fa",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-seres-therapeutics-qtrly-net-loss/brief-seres-therapeutics-qtrly-net-loss-of-29-0-mln-vs-25-3-mln-idUSASB0C9EB",
    "ord_in_thread": 0,
    "title": "BRIEF-Seres Therapeutics Qtrly Net Loss Of $29.0 Mln Vs $25.3 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Seres Therapeutics Inc:\n* SERES THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES\n* SERES THERAPEUTICS INC - QTRLY NET LOSS OF $29.0 MILLION VERSUS $25.3 MILLION Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-08T20:06:00.000+02:00",
    "crawled": "2018-03-09T14:23:56.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "seres",
        "therapeutic",
        "inc",
        "seres",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "seres",
        "therapeutic",
        "inc",
        "qtrly",
        "net",
        "loss",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}